A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease (Q42654018)

4 November 2017

title

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease (English)

1 reference

randomized controlled trial

4 November 2017

0 references

1 reference

0 references

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

Giulio Marchesini

0 references

Elisabetta Bugianesi

1 reference

4 November 2017

Mario Rizzetto

1 reference

4 November 2017

Elena Gentilcore

1 reference

4 November 2017

Rita Manini

1 reference

4 November 2017

Stefania Natale

1 reference

4 November 2017

Ester Vanni

1 reference

4 November 2017

Nicola Villanova

1 reference

4 November 2017

Ezio David

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

The American Journal of Gastroenterology

4 November 2017

published in

1 reference

4 November 2017

volume

100

1 reference

4 November 2017

1 reference

4 November 2017

page(s)

1082-1090

1 reference

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

Metformin in non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

Metformin in the treatment of patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

Vitamins E and C for the treatment of NASH: duplication of results but lack of demonstration of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

AHA Science Advisory: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

Fatty liver--an additional and treatable feature of the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

Metformin reverses fatty liver disease in obese, leptin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

Improved endothelial function with metformin in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41583.X

10.1111/J.1572-0241.2005.41583.X

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference